{"id":"https://openalex.org/W3134770103","doi":"https://doi.org/10.1158/0008-5472.can-20-2178","title":"Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors","display_name":"Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors","alternate_titles":[],"publication_year":2021,"publication_date":"2021-03-09","ids":{"openalex":"https://openalex.org/W3134770103","doi":"https://doi.org/10.1158/0008-5472.can-20-2178","mag":"3134770103","pmid":"https://pubmed.ncbi.nlm.nih.gov/33687950"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-20-2178","doi":"https://doi.org/10.1158/0008-5472.can-20-2178","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-20-2178","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3134770103"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019593738","display_name":"Darren C. Phillips","orcid":"https://orcid.org/0009-0000-6760-9759","observed_orcids":["https://orcid.org/0009-0000-6760-9759"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Darren C. Phillips","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061227640","display_name":"F. Gregory Buchanan","orcid":"https://orcid.org/0000-0003-2709-1558","observed_orcids":["https://orcid.org/0000-0003-2709-1558"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fritz G. Buchanan","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031829020","display_name":"Dong Cheng","orcid":"https://orcid.org/0000-0002-2891-8759","observed_orcids":["https://orcid.org/0000-0002-2891-8759"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Cheng","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833430","display_name":"Larry R. Solomon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry R. Solomon","raw_affiliation_strings":["2AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022636146","display_name":"Xiao Hong Yu","orcid":"https://orcid.org/0000-0003-2491-9110","observed_orcids":["https://orcid.org/0000-0003-2491-9110"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Xiao","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109172043","display_name":"John Xue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Xue","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107007628","display_name":"Stephen K. Tahir","orcid":"https://orcid.org/0009-0004-7932-0353","observed_orcids":["https://orcid.org/0009-0004-7932-0353"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen K. Tahir","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040158129","display_name":"Morey L. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morey L. Smith","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101758341","display_name":"Haichao Zhang","orcid":"https://orcid.org/0000-0003-0154-2947","observed_orcids":["https://orcid.org/0000-0003-0154-2947"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haichao Zhang","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033898620","display_name":"Deborah L. Widomski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Widomski","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103113971","display_name":"Vivek C. Abraham","orcid":"https://orcid.org/0000-0003-3150-9638","observed_orcids":["https://orcid.org/0000-0003-3150-9638"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek C. Abraham","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064813104","display_name":"Nan Xu","orcid":"https://orcid.org/0000-0003-1212-7773","observed_orcids":["https://orcid.org/0000-0003-1212-7773","https://orcid.org/0009-0004-6958-0004"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nan Xu","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100394554","display_name":"Zhihong Liu","orcid":"https://orcid.org/0000-0001-6093-0726","observed_orcids":["https://orcid.org/0000-0001-6093-0726"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhihong Liu","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072190929","display_name":"Li Zhou","orcid":"https://orcid.org/0000-0002-9683-3562","observed_orcids":["https://orcid.org/0000-0002-9683-3562"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Zhou","raw_affiliation_strings":["3Protein Biochemistry, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-9683-3562","affiliations":[{"raw_affiliation_string":"3Protein Biochemistry, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073044716","display_name":"Enrico L. DiGiammarino","orcid":"https://orcid.org/0000-0001-8711-7292","observed_orcids":["https://orcid.org/0000-0001-8711-7292"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrico DiGiammarino","raw_affiliation_strings":["3Protein Biochemistry, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Protein Biochemistry, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101606912","display_name":"Xin L. Lu","orcid":"https://orcid.org/0000-0002-6612-8352","observed_orcids":["https://orcid.org/0000-0002-6612-8352"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Lu","raw_affiliation_strings":["4Genomic Research Center, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Genomic Research Center, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060993657","display_name":"Nandini Rudra-Ganguly","orcid":"https://orcid.org/0009-0002-4270-5714","observed_orcids":["https://orcid.org/0009-0002-4270-5714"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nandini Rudra-Ganguly","raw_affiliation_strings":["5Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003574675","display_name":"Bruce A. Trela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce Trela","raw_affiliation_strings":["6Pre-clinical Safety, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Pre-clinical Safety, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036288399","display_name":"Susan E. Morgan-Lappe","orcid":"https://orcid.org/0000-0002-0089-0416","observed_orcids":["https://orcid.org/0000-0002-0089-0416"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan E. Morgan-Lappe","raw_affiliation_strings":["1Oncology Discovery, AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-0089-0416","affiliations":[{"raw_affiliation_string":"1Oncology Discovery, AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019593738"],"corresponding_institution_ids":["https://openalex.org/I2948539688"],"apc_list":null,"apc_paid":null,"fwci":2.3508,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.91258844,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"81","issue":"12","first_page":"3402","last_page":"3414"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail-receptor-agonists","display_name":"TRAIL receptor agonists","score":0.9100000262260437},{"id":"https://openalex.org/keywords/dr4","display_name":"DR4","score":0.6629999876022339},{"id":"https://openalex.org/keywords/dr5","display_name":"DR5","score":1.0},{"id":"https://openalex.org/keywords/death-receptor-signaling","display_name":"death receptor signaling","score":0.6629999876022339},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7020000219345093},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.7549999952316284},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bcl-xl-inhibitors","display_name":"Bcl-xL inhibitors","score":0.7960000038146973},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6790078282356262},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6019551157951355},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5722267627716064},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5659838318824768},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5607396364212036},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.46326854825019836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42659544944763184},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.42462074756622314},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.41296011209487915},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3970871567726135},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35755810141563416},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32001060247421265},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.280632346868515},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18979942798614502},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10921499133110046},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.09668537974357605},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005164","descriptor_name":"Factor IX","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-20-2178","doi":"https://doi.org/10.1158/0008-5472.can-20-2178","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-20-2178","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:33687950","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33687950","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W145426927","https://openalex.org/W1910698471","https://openalex.org/W1964619821","https://openalex.org/W1971563492","https://openalex.org/W1974144614","https://openalex.org/W1983863419","https://openalex.org/W1991388076","https://openalex.org/W2008465548","https://openalex.org/W2019607817","https://openalex.org/W2022265958","https://openalex.org/W2044046394","https://openalex.org/W2074106785","https://openalex.org/W2084322562","https://openalex.org/W2084376588","https://openalex.org/W2106284224","https://openalex.org/W2107610558","https://openalex.org/W2110525250","https://openalex.org/W2115147179","https://openalex.org/W2154344002","https://openalex.org/W2166215505","https://openalex.org/W2166566481","https://openalex.org/W2168632005","https://openalex.org/W2169344120","https://openalex.org/W2170364001","https://openalex.org/W2172242534","https://openalex.org/W2290145688","https://openalex.org/W2319486658","https://openalex.org/W2320870975","https://openalex.org/W2414279676","https://openalex.org/W2443320391","https://openalex.org/W2515452313","https://openalex.org/W2620490360","https://openalex.org/W2754871120","https://openalex.org/W2766023905","https://openalex.org/W2769631482","https://openalex.org/W2770858121","https://openalex.org/W2799281825","https://openalex.org/W2891164466","https://openalex.org/W2904016068","https://openalex.org/W2971799124","https://openalex.org/W3093302259","https://openalex.org/W3134530972","https://openalex.org/W4244578979","https://openalex.org/W6605939905","https://openalex.org/W6639897207"],"related_works":["https://openalex.org/W3094703560","https://openalex.org/W3183136707","https://openalex.org/W2944805298","https://openalex.org/W2947419359","https://openalex.org/W2741083064","https://openalex.org/W2166566481","https://openalex.org/W4233823561","https://openalex.org/W2955497764","https://openalex.org/W4224310547","https://openalex.org/W2060032334"],"abstract_inverted_index":{"Abstract":[0],"TRAIL":[1,28,45],"can":[2],"activate":[3],"cell":[4,12,98,107],"surface":[5],"death":[6,13,99],"receptors,":[7],"resulting":[8],"in":[9,93,100,109,115,130,156,170,184,206,237,254],"potent":[10],"tumor":[11,127],"via":[14],"induction":[15],"of":[16,41,81,91,104,121,135,151,181,214,235,247,257],"the":[17,57,149,179,225,233,245],"extrinsic":[18],"apoptosis":[19],"pathway.":[20],"Eftozanermin":[21],"alfa":[22],"(ABBV-621)":[23],"is":[24],"a":[25,221,248],"second":[26],"generation":[27],"receptor":[29,46],"agonist":[30],"engineered":[31],"as":[32],"an":[33,131],"IgG1-Fc":[34],"mutant":[35],"backbone":[36],"linked":[37],"to":[38,56,66,153,200],"two":[39],"sets":[40],"trimeric":[42],"native":[43],"single-chain":[44],"binding":[47],"domain":[48],"monomers.":[49],"This":[50,242],"hexavalent":[51,249],"agonistic":[52,251],"fusion":[53,252],"protein":[54,253],"binds":[55],"death-inducing":[58,76],"DR4":[59,139],"and":[60,75,84,165,167,189],"DR5":[61,142],"receptors":[62],"with":[63,71,162,208,211,239],"nanomolar":[64],"affinity":[65],"drive":[67],"on-target":[68],"biological":[69],"activity":[70,123,155,234,246],"enhanced":[72],"caspase-8":[73],"aggregation":[74],"signaling":[77],"complex":[78],"formation":[79],"independent":[80],"Fc\u03b3R-mediated":[82],"cross-linking,":[83],"without":[85],"clinical":[86,229],"signs":[87],"or":[88,210],"pathologic":[89],"evidence":[90],"toxicity":[92],"nonrodent":[94],"species.":[95],"ABBV-621":[96,122,154,182,201,236],"induced":[97],"approximately":[101],"36%":[102],"(45/126)":[103],"solid":[105,258],"cancer":[106,186,191],"lines":[108],"vitro":[110],"at":[111],"subnanomolar":[112],"concentrations.":[113],"An":[114],"vivo":[116],"patient-derived":[117],"xenograft":[118],"(PDX)":[119],"screen":[120],"across":[124],"15":[125],"different":[126],"indications":[128],"resulted":[129],"overall":[132],"response":[133,152],"(OR)":[134],"29%":[136],"(47/162).":[137],"Although":[138],"(TNFSFR10A)":[140],"and/or":[141],"(TNFSFR10B)":[143],"expression":[144],"levels":[145],"did":[146],"not":[147],"predict":[148],"level":[150],"vivo,":[157],"KRAS":[158],"mutations":[159],"were":[160,168],"associated":[161],"elevated":[163],"TNFSFR10A":[164],"TNFSFR10B":[166],"enriched":[169],"ABBV-621\u2013responsive":[171],"colorectal":[172,185],"carcinoma":[173],"PDX":[174],"models.":[175],"To":[176],"build":[177],"upon":[178],"OR":[180],"monotherapy":[183],"(45%;":[187],"10/22)":[188],"pancreatic":[190],"(35%;":[192],"7/20),":[193],"we":[194],"subsequently":[195],"demonstrated":[196],"that":[197,260],"inherent":[198],"resistance":[199],"treatment":[202],"could":[203],"be":[204],"overcome":[205],"combination":[207],"chemotherapeutics":[209],"selective":[212],"inhibitors":[213],"BCL-XL.":[215],"In":[216],"summary,":[217],"these":[218],"data":[219],"provide":[220],"preclinical":[222,255],"rationale":[223],"for":[224],"ongoing":[226],"phase":[227],"1":[228],"trial":[230],"(NCT03082209)":[231],"evaluating":[232],"patients":[238],"cancer.":[240],"Significance:":[241],"study":[243],"describes":[244],"TRAIL-receptor":[250],"models":[256],"tumors":[259],"mechanistically":[261],"distinguishes":[262],"this":[263],"molecular":[264],"entity":[265],"from":[266],"other":[267],"TRAIL-based":[268],"therapeutics.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3134770103","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-03-15T00:00:00"}
